Home > > > What Is Driving the Growth of the Global Next-Generation Sequencing Market?

What Is Driving the Growth of the Global Next-Generation Sequencing Market?

Author : Eknath Girhepunje | Published On : 03 Jul 2026

Next-Generation Sequencing Market

The global next-generation sequencing (NGS) market is experiencing remarkable growth due to increasing adoption of precision medicine, rapid advancements in genomic research, and expanding clinical applications in oncology, rare diseases, and infectious disease diagnostics. The next-generation sequencing market size was valued at USD 12.65 billion in 2025 and is projected to grow from USD 14.88 billion in 2026 to USD 56.07 billion by 2034, registering a CAGR of 18.03% during the forecast period (2026–2034).

Next-generation sequencing is an advanced genomic technology that enables rapid, high-throughput analysis of DNA and RNA sequences with exceptional accuracy and cost efficiency. NGS has transformed genetic research by allowing scientists and clinicians to sequence millions of DNA fragments simultaneously, supporting applications such as cancer genomics, reproductive health, infectious disease surveillance, pharmacogenomics, and personalized medicine. Continuous technological innovation and declining sequencing costs continue driving widespread adoption across research institutions, hospitals, pharmaceutical companies, and biotechnology organizations.

For detailed market insights, growth forecasts, and competitive analysis, visit:

https://straitsresearch.com/report/next-generation-sequencing-market

Market Drivers

Growing Adoption of Precision Medicine

Precision medicine is becoming an integral part of modern healthcare by enabling treatments tailored to individual genetic profiles. Next-generation sequencing plays a vital role in identifying disease-causing mutations, predicting treatment response, and supporting targeted therapies for cancer and rare genetic disorders.

The increasing integration of genomic data into clinical decision-making continues driving market expansion.

Rapid Advancements in Genomic Research

Governments, research institutions, and biotechnology companies are significantly increasing investments in genomics research. Large-scale genome sequencing initiatives and expanding clinical studies are accelerating the development of innovative diagnostic and therapeutic solutions.

Advances in sequencing chemistry, bioinformatics, and artificial intelligence are further improving sequencing speed and accuracy.

Rising Demand for Early Disease Detection

Healthcare providers are increasingly utilizing NGS for early diagnosis of hereditary disorders, infectious diseases, prenatal conditions, and cancer. Early detection enables timely intervention, improved patient outcomes, and more effective treatment planning.

Growing awareness of preventive healthcare continues supporting market growth.

Market Challenges

High Infrastructure and Data Analysis Costs

Although sequencing costs have declined considerably, establishing NGS laboratories requires significant investment in sequencing platforms, computational infrastructure, and specialized personnel. Managing and interpreting large genomic datasets also remains technically challenging.

Healthcare organizations continue investing in cloud computing and AI-powered bioinformatics solutions to improve efficiency.

Regulatory and Ethical Considerations

Clinical genomic testing involves complex regulatory requirements related to patient privacy, genetic data security, and diagnostic validation. Compliance with international standards remains essential for healthcare providers and sequencing laboratories.

Ongoing regulatory harmonization is expected to support broader adoption.

Market Segmentation

By Product

The market is segmented into sequencing platforms, consumables, reagents, sample preparation kits, and bioinformatics software. Consumables account for the largest market share due to their recurring use in sequencing workflows and increasing testing volumes.

Bioinformatics solutions are expected to witness rapid growth as genomic data generation continues expanding.

By Technology

The market includes sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing, single-molecule real-time (SMRT) sequencing, and other advanced sequencing technologies. Sequencing by synthesis dominates the market owing to its high accuracy, scalability, and widespread commercial adoption.

Long-read sequencing technologies are gaining increasing attention for complex genome analysis.

By Application

Major applications include oncology, clinical diagnostics, reproductive health, infectious disease diagnostics, agricultural genomics, drug discovery, and academic research. Oncology remains the leading application segment due to increasing use of genomic profiling for precision cancer treatment.

Clinical diagnostics is expected to experience substantial growth during the forecast period.

By End User

Major end users include hospitals, diagnostic laboratories, pharmaceutical companies, biotechnology firms, academic research institutes, and government organizations. Research institutions and biotechnology companies account for a significant market share because of ongoing genomic research and drug development activities.

Hospitals are increasingly integrating NGS into routine clinical practice.

Regional Insights

North America

North America dominates the next-generation sequencing market due to advanced healthcare infrastructure, substantial research funding, strong biotechnology ecosystems, and widespread adoption of precision medicine. The United States remains the largest regional market.

Europe

Europe represents a major market supported by expanding genomics research, increasing government funding, and growing clinical adoption of NGS technologies. Germany, the United Kingdom, France, and Switzerland remain key contributors.

Asia-Pacific

Asia-Pacific is expected to witness the fastest growth during the forecast period. Increasing healthcare expenditure, expanding biotechnology industries, rising investments in genomic medicine, and growing demand for advanced diagnostics are driving market expansion across China, Japan, India, South Korea, and Singapore.

Government-supported genome sequencing initiatives continue strengthening regional growth.

Latin America, Middle East & Africa

These regions are gradually increasing investments in molecular diagnostics and genomic research through healthcare modernization and international collaborations. Continued infrastructure development is expected to create future market opportunities.

Key Players Analysis

The next-generation sequencing market is highly competitive, with leading companies focusing on high-throughput sequencing platforms, AI-powered bioinformatics, long-read sequencing technologies, and automated sample preparation solutions. Manufacturers continue investing in research and development, strategic partnerships, and global expansion to strengthen their competitive positions.

Innovations in single-cell sequencing, liquid biopsy, multi-omics integration, and cloud-based genomic analysis are expected to shape the future of the industry.

Key Companies

  • Illumina, Inc.

  • Thermo Fisher Scientific Inc.

  • Pacific Biosciences of California, Inc.

  • Oxford Nanopore Technologies plc

  • BGI Genomics Co., Ltd.

  • QIAGEN N.V.

  • F. Hoffmann-La Roche Ltd.

  • Agilent Technologies, Inc.

  • PerkinElmer, Inc.

  • Revvity, Inc.

Conclusion

The global next-generation sequencing market is expected to witness exceptional growth through 2034, driven by expanding precision medicine, increasing genomic research, and rising demand for advanced molecular diagnostics. Although infrastructure costs and regulatory challenges remain significant barriers, continuous technological advancements and growing healthcare investments are expected to create substantial growth opportunities. As genomics becomes increasingly central to personalized healthcare, next-generation sequencing will continue transforming disease diagnosis, drug development, and precision therapeutics.

About Us

Straits Research is a leading market research and intelligence organization specializing in research, analytics, and advisory services. The company provides comprehensive market reports, industry insights, and strategic business intelligence across multiple industries, helping organizations identify growth opportunities and make informed business decisions.

Contact Us

Email: [email protected]

Tel: +1 646 905 0080 (U.S.)

Tel: +44 203 695 0070 (U.K.)